[Pulmonary sarcoidosis. Presumptions, facts].
D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D006386:Hemagglutination Tests; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D008171:Lung Diseases / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology; D008213:Lymphocyte Activation; D011379:Prognosis; D011877:Radionuclide Imaging; D012217:Rheumatoid Factor / Q000302:isolation & purification; D012507:Sarcoidosis / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology; D014397:Tuberculosis, Pulmonary / Q000150:complications
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D002738:Chloroquine; D012217:Rheumatoid Factor
Die Lungensarkoidose. Vermutungen, Tatsachen